Sort by
Refine Your Search
-
novel MOP/NOP dual receptor agonist, as a safer and more effective treatment for opioid use disorder (OUD). Unlike current OUD therapies that target only MOP receptors, cebranopadol's dual mechanism has
Enter an email to receive alerts for algorithm-sensor-"DIFFER" positions